Merit Medical Systems, Inc. (MMSI) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Merit Medical Systems, Inc. (MMSI) Healthcare & Pipeline Overview

Merit Medical Systems, Inc. develops and markets single-use medical devices, primarily for interventional procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company's global reach and focus on specialized medical fields position it as a key player in the medical instruments and supplies industry.

What Is the Investment Thesis for MMSI?

With a P/E ratio of 35.29 and a profit margin of 9.0%, the company demonstrates financial stability. Key growth catalysts include expansion of its product portfolio and strategic acquisitions. However, investors may want to evaluate risks such as competition from established medical device manufacturers and potential regulatory changes. The company's gross margin of 48.7% indicates efficient operations and pricing power.

Based on FMP financials and quantitative analysis

MMSI Key Highlights

Market capitalization of $5.16B, reflecting investor confidence in the company's growth potential.

• P/E ratio of 35.29, indicating a valuation in line with earnings.
• Gross margin of 48.7%, showcasing efficient production and pricing strategies.
• Profit margin of 9.0%, demonstrating the company's ability to convert revenue into profit.
• Beta of 0.65, suggesting lower volatility compared to the overall market.

Who Are MMSI's Competitors?

MMSI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are MMSI's Key Strengths?

Specialized product portfolio in interventional procedures.

• Established relationships with hospitals and physicians.
• Direct sales force and distribution network.
• Custom procedural solutions.

What Are MMSI's Weaknesses?

Reliance on single-use medical devices.

• Exposure to regulatory changes in the medical device industry.
• Competition from larger medical device manufacturers.
• Potential for product liability claims.

What Could Drive MMSI Stock Higher?

Expansion of product portfolio through internal R&D and acquisitions.

• Geographic expansion into emerging markets.
• Potential regulatory approvals for new medical devices.
• Increased adoption of minimally invasive procedures driving demand for Merit Medical's products.

What Are the Key Risks for MMSI?

Rich valuation — a P/E of 35.29 runs well above the Healthcare sector’s ~21.50x, leaving little room for a miss.

• Insider selling — insiders were net sellers of roughly $1.5M recently.
• Competition from larger medical device manufacturers.
• Pricing pressures from hospitals and healthcare providers.
• Regulatory changes affecting medical device approvals and reimbursement.
• Economic downturns impacting healthcare spending.
• Product liability claims related to medical devices.

What Are the Growth Opportunities for MMSI?

• Expansion of Product Portfolio: Merit Medical can drive growth by expanding its product portfolio through internal research and development and strategic acquisitions. Focusing on innovative devices for emerging interventional procedures can capture new market segments. The market for interventional cardiology devices alone is projected to reach $25 billion by 2028, offering a significant growth opportunity.
• Geographic Expansion: Expanding into emerging markets, particularly in Asia-Pacific and Latin America, presents a significant growth opportunity. These regions have a growing middle class and increasing access to healthcare, driving demand for medical devices. The Asia-Pacific medical device market is expected to grow at a CAGR of 8% over the next five years, making it an attractive target for Merit Medical.
• Strategic Acquisitions: Merit Medical can accelerate growth through strategic acquisitions of complementary businesses and technologies. Acquiring companies with innovative products or established market positions can expand the company's product portfolio and geographic reach. The medical device industry is highly fragmented, offering numerous acquisition opportunities.
• Increased Focus on Custom Procedural Solutions: The company's custom procedural solutions, including critical care products and disinfection protection systems, offer a high-margin growth opportunity. By tailoring solutions to specific customer needs, Merit Medical can differentiate itself from competitors and build strong customer relationships. The market for custom procedure trays is projected to reach $10 billion by 2027.
• Leveraging Direct Sales Force and Distribution Network: Merit Medical can leverage its existing direct sales force and distribution network to drive sales of new and existing products. By strengthening relationships with hospitals and physicians, the company can increase market share and improve customer retention. The company's established distribution network provides a competitive advantage in reaching customers in both domestic and international markets.

What Are MMSI's Competitive Advantages?

• Specialized product portfolio focused on interventional procedures.
• Established relationships with hospitals and physicians.
• Direct sales force and distribution network.
• Custom procedural solutions tailored to customer needs.

What Does MMSI Do?

Merit Medical Systems, Inc., founded in 1987 and headquartered in South Jordan, Utah, designs, develops, manufactures, and markets single-use medical products. These products are primarily used in interventional, diagnostic, and therapeutic procedures across various medical specialties, including cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two segments: Cardiovascular and Endoscopy. The Cardiovascular segment offers products for peripheral and cardiac interventions, addressing diseases in peripheral vessels and organs and various heart conditions. These include access, angiography, electrophysiology, cardiac rhythm management, fluid management, hemodynamic monitoring, and hemostasis products. The Endoscopy segment provides pulmonary products, gastroenterology products, and kits and accessories for endoscopy and bronchoscopy procedures. Merit Medical also offers custom procedural solutions, including critical care products, disinfection protection systems, syringes, manifold kits, trays and packs, coated tubes and wires, and sensor components for microelectromechanical systems. The company distributes its products globally through a direct sales force, distributors, original equipment manufacturer partners, and custom procedure tray manufacturers, serving hospitals and alternate site-based physicians, technicians, and nurses.

What Products and Services Does MMSI Offer?

• Designs, develops, and manufactures single-use medical products.
• Offers products for interventional, diagnostic, and therapeutic procedures.
• Specializes in cardiology, radiology, oncology, critical care, and endoscopy.
• Provides peripheral intervention products for treating diseases in vessels and organs.
• Offers cardiac intervention products for various heart conditions.
• Supplies custom procedural solutions, including critical care products and disinfection systems.
• Sells products to hospitals and physicians through direct sales and distributors.

How Does MMSI Make Money?

• Develops and manufactures single-use medical devices.
• Sells products through a direct sales force and distribution network.
• Generates revenue from product sales to hospitals, physicians, and OEM partners.
• Offers custom procedural solutions for specific customer needs.

What Industry Does MMSI Operate In?

Merit Medical Systems operates in the medical instruments and supplies industry, a sector driven by technological advancements, an aging global population, and increasing healthcare expenditure. The market is competitive, with established players and emerging companies vying for market share. Merit Medical's focus on single-use devices for interventional procedures positions it to capitalize on the trend toward minimally invasive treatments. The global medical devices market is projected to reach $600 billion by 2028, growing at a CAGR of 5.4%.

Who Are MMSI's Key Customers?

• Physicians (cardiologists, radiologists, oncologists, etc.)
• Technicians and nurses
• Original equipment manufacturer (OEM) partners
• Custom procedure tray manufacturers

Over the past six months, Merit Medical Systems, Inc. insiders filed 23 SEC Form 4 transactions — 7 sales and 16 purchases. On net that is roughly 18K shares acquired (about $1.5M) — insiders putting money in tends to read as conviction.

Merit Medical Systems, Inc. has beaten Wall Street's EPS estimate in 8 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 13.7% above estimates on average.

Merit Medical Systems, Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 4.25 places it in the safe zone, indicating low near-term bankruptcy risk.

Return on equity for Merit Medical Systems, Inc. stands at 9.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 5.1%, showing how much profit it generates from its asset base. MMSI trades at a trailing price-to-earnings ratio of 35.29, above the Healthcare sector average of ~21.50x. Its free cash flow yield is 3.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 4.20 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.7%, the inverse of the P/E and a quick read on earnings relative to price.

Merit Medical Systems, Inc. (MMSI) Valuation Context

Valued at $5.16B, MMSI is classified as a mid-cap stock. Analyst price targets span from $94.00 to $114.00, with a consensus of $101.88. At the current price of $86.47, that implies approximately 18% upside potential. Relative to its peer group, MMSI's quantitative score of 84/100 is above the peer average of 65/100.

MMSI Revenue & Earnings Trend

In Q2 FY2026, MMSI generated $418.8M in top-line revenue, marking a sequential increase of 9.7%. The company recorded net income of $38.8M, with diluted EPS of $0.65. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Healthcare. Across the four most recent quarters, MMSI averaged $0.61 in diluted EPS.

Company Profile

Merit Medical Systems, Inc. operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in South Jordan, US. The company is led by CEO Martha Goldberg Aronson. MMSI has traded publicly since 1990.

MMSI Financials

MMSI Latest News

MMSI Analyst Consensus

MMSI MoonshotScore

Latest Merit Medical Systems, Inc. Analysis

MMSI Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources